Headquartered in New York, NY Fiscal year ends December NASDAQ: CCXI churchillcapital-11.com
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.
Wednesday's top analyst upgrades and downgrades included Academy Sports & Outdoors, Arista Networks, Colgate-Palmolive, Expedia, Global Payments, Huntsman, InMode, ON Semiconductor and Zoominfo Technologies.
Friday's top analyst upgrades and downgrades included Allstate, Cisco Systems, CSX, FIGS, Meta Platforms, Nike, ON Semiconductor, Pinterest, SentinelOne and Zscaler.
Monday's top analyst upgrades and downgrades included Carvana, Cloudflare, Comcast, ConocoPhillips, Constellation Brands, Exxon Mobil, Eli Lilly, SoFi Technologies and Starbucks.
Wednesday's top analyst upgrades and downgrades included American Airlines, Bank of America, Masco, Morgan Stanley, Rite Aid and Wells Fargo.
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.
